Please check your internet connection and try again.
# Montelukast/Levocetirizine
## Overview
Montelukast is a leukotriene receptor antagonist. Levocetirizine is a second-generation antihistamine. This combination is used for the management of allergic rhinitis symptoms.
## Primary Indications
Allergic rhinitis (seasonal and perennial).
## Adult Dosing
* Montelukast 10 mg orally once daily.
* Levocetirizine 5 mg orally once daily.
* The combination is typically administered as a single tablet containing both active ingredients.
* Maximum daily dose: Montelukast 10 mg, Levocetirizine 5 mg.
## Pediatric Dosing
Dosing is dependent on age and weight and should be determined based on the specific product formulation and local guidelines.
* For children aged 6 years and older: The dose is typically 5 mg montelukast and 2.5 mg levocetirizine once daily.
* For children aged 2 to 5 years: The dose is typically 4 mg montelukast and 2.5 mg levocetirizine once daily (may be available as a chewable tablet or oral granules).
* Use in children younger than 2 years is generally not recommended unless specifically guided by a healthcare provider.
## Dose Adjustments
* **Renal Impairment:** Levocetirizine requires dose adjustment in moderate to severe renal impairment. Montelukast does not typically require dose adjustment. Consult specific product labeling for detailed recommendations.
* **Hepatic Impairment:** Montelukast may require dose adjustment in significant hepatic impairment. Consult specific product labeling for detailed recommendations.
## Contraindications
* Hypersensitivity to montelukast, levocetirizine, or any component of the formulation.
* Severe renal impairment (for levocetirizine).
## Adverse Effects
* **Montelukast:** Neuropsychiatric events (e.g., depression, suicidal ideation, anxiety, insomnia, agitation), headache, abdominal pain, cough.
* **Levocetirizine:** Somnolence, fatigue, dry mouth, pharyngitis, dizziness.
## Key Drug Interactions
* **CYP1A2 inhibitors/inducers:** May affect montelukast metabolism, though clinical significance is often limited.
* **CNS Depressants:** Additive sedative effects with levocetirizine.
## Monitoring
* Monitor for reported neuropsychiatric effects with montelukast.
* Monitor for somnolence and impaired cognitive function with levocetirizine.
## Clinical Pearls
* Montelukast carries a boxed warning regarding neuropsychiatric events. Patients and caregivers should be advised to report any behavioral or mood changes.
* Levocetirizine can cause significant somnolence. Advise caution with activities requiring mental alertness.
* The combination is generally taken once daily, usually in the evening, especially if somnolence is a concern.
***
**Disclaimer**: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and local guidelines before making any treatment decisions.
